Nutrient quality
Enteric delivery and clearly named enzyme sources support systemic use, though activity units are missing. The supplied amounts support practical use for the intended purpose.
.| $ 28.21 | ||
| $ 31.49 |
Pancreatin, papain, bromelain, trypsin, and chymotrypsin cover multiple protein-degrading pathways. Rutin is listed at 150 mg and fits the joint-health positioning.
Enzyme activity units are absent, and the label repeats 150 mg rutin under the compound and plant source. It is unclear whether those entries describe one amount or two, while protected delivery may delay release beyond the stomach.
The 33-serving bottle offers only moderate trial length and weak serving value. The formula makes more sense for systemic-joint positioning than as a straightforward meal-time digestive enzyme.
Enteric delivery and clearly named enzyme sources support systemic use, though activity units are missing. The supplied amounts support practical use for the intended purpose.
.The active weights are clearly listed, making the core formula possible to assess. Activity units, intake timing, and non-active ingredients are absent from the supplied data.
.The supplied average is very strong and the response volume is moderate. No detailed feedback is provided to assess recurring complaints or fit with the intended purpose.
.The serving may be economical, but missing enzyme activity limits confidence in value. A better standardized or more effectively dosed product would provide a stronger comparison.
.Papain, bromelain, pancreatin, trypsin, and chymotrypsin provide broad protein-digesting enzyme coverage. The enteric coating protects the enzymes, but the joint-focused product may be intended for between-meal systemic use rather than digestion with food.
Ingredient weights are clear, yet no enzyme activity units show actual digestive potency. Bromelain and papain may increase bleeding risk with anticoagulant or antiplatelet medicines and may trigger reactions in people sensitive to pineapple or papaya.
| Ingredient | Amount per serving |
|---|---|
Pancreatin (Pancreas) | 300 mg |
Papain (Carica papaya) | 180 mg |
Bromelain (Ananas comosus) | 135 mg |
Trypsin (Pancreas) | 72 mg |
Chymotrypsin (Pancreas) | 3 mg |
Rutoside Trihydrate (Rutin, Sophora japonica) | 150 mg |
The papaya-derived papain is supplied at a high, clearly disclosed amount. Enteric-coated tablets support delivery beyond the stomach, but the label gives weight rather than standardized enzyme activity, so actual potency remains uncertain. The serving is relatively costly, though the high dose and specialized coating provide meaningful value support.
The identified Sophora japonica source and trihydrate form provide strong ingredient transparency. Its disclosed rutin amount is modest and below the higher targeted range. The serving cost results in average value for the amount supplied.
The enteric-coated tablet is well aligned with systemic joint use because it helps protect enzymes through the stomach. The formula supplies a meaningful amount of bromelain alongside other proteolytic enzymes, but its enzyme activity is not disclosed. Value is weak for the bromelain delivered, and the label details provided do not clarify whether it should be taken between meals.
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.